Literature DB >> 28656617

Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH.

Y Dargaud1, A S Wolberg2, E Gray3, C Negrier1, H C Hemker4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28656617      PMCID: PMC5680042          DOI: 10.1111/jth.13743

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  28 in total

1.  The thrombogram: monitoring thrombin generation in platelet-rich plasma.

Authors:  H C Hemker; P L Giesen; M Ramjee; R Wagenvoord; S Béguin
Journal:  Thromb Haemost       Date:  2000-04       Impact factor: 5.249

2.  Platelet-dependent thrombography: a method for diagnostic laboratories.

Authors:  Yesim Dargaud; Roger Luddington; Trevor Baglin
Journal:  Br J Haematol       Date:  2006-08       Impact factor: 6.998

3.  Elimination of contact factor activation improves measurement of platelet-dependent thrombin generation by calibrated automated thrombography at low-concentration tissue factor.

Authors:  Y Dargaud; R Luddington; T P Baglin
Journal:  J Thromb Haemost       Date:  2006-05       Impact factor: 5.824

4.  Standardisation of thrombin generation test--which reference plasma for TGT? An international multicentre study.

Authors:  Y Dargaud; R Luddington; E Gray; T Lecompte; T Siegemund; T Baglin; J Hogwood; V Regnault; A Siegemund; C Negrier
Journal:  Thromb Res       Date:  2009-11-26       Impact factor: 3.944

5.  Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery.

Authors:  Yesim Dargaud; Anne Lienhart; Claude Negrier
Journal:  Blood       Date:  2010-09-01       Impact factor: 22.113

6.  Thrombin generation in patients with factor XI deficiency and clinical bleeding risk.

Authors:  L Rugeri; F Quélin; B Chatard; P De Mazancourt; C Negrier; Y Dargaud
Journal:  Haemophilia       Date:  2010-04-08       Impact factor: 4.287

7.  Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B.

Authors:  Yesim Dargaud; Suzette Béguin; Anne Lienhart; Raed Al Dieri; Christine Trzeciak; Jean Claude Bordet; H Coenraad Hemker; Claude Negrier
Journal:  Thromb Haemost       Date:  2005-03       Impact factor: 5.249

8.  Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition.

Authors:  R Luddington; T Baglin
Journal:  J Thromb Haemost       Date:  2004-11       Impact factor: 5.824

Review 9.  Thrombin generation testing in haemophilia comprehensive care centres.

Authors:  Y Dargaud; C Negrier
Journal:  Haemophilia       Date:  2009-08-27       Impact factor: 4.287

10.  Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study.

Authors:  Yesim Dargaud; Rodger Luddington; Elaine Gray; Claude Negrier; Thomas Lecompte; Sirak Petros; John Hogwood; Jean-Claude Bordet; Veronique Regnault; Annelie Siegemund; Trevor Baglin
Journal:  Br J Haematol       Date:  2007-10       Impact factor: 6.998

View more
  24 in total

1.  Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab.

Authors:  Yesim Dargaud; Anne Lienhart; Maissaa Janbain; Sandra Le Quellec; Nathalie Enjolras; Claude Negrier
Journal:  Haematologica       Date:  2018-02-22       Impact factor: 9.941

Review 2.  Global coagulation assays in hypercoagulable states.

Authors:  Hui Yin Lim; Geoffrey Donnan; Harshal Nandurkar; Prahlad Ho
Journal:  J Thromb Thrombolysis       Date:  2022-01-08       Impact factor: 2.300

3.  Applicability of the Thrombin Generation Test to Evaluate the Hemostatic Status of Hemophilia A Patients in Daily Clinical Practice.

Authors:  Ángel Bernardo; Alberto Caro; Daniel Martínez-Carballeira; José Ramón Corte; Sonia Vázquez; Carmen Palomo-Antequera; Alfredo Andreu; Álvaro Fernández-Pardo; Julia Oto; Laura Gutiérrez; Inmaculada Soto; Pilar Medina
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

4.  Circulating Small Extracellular Vesicles Profiling and Thrombin Generation as Potential Markers of Thrombotic Risk in Glioma Patients.

Authors:  Olga Melnichnikova; Yulia Zhilenkova; Olga Sirotkina; Ekaterina Zolotova; Konstantin Pishchulov; Malik Tastanbekov; Artem Paltsev; Maria Simakova
Journal:  Front Cardiovasc Med       Date:  2022-06-23

5.  Kallikrein augments the anticoagulant function of the protein C system in thrombin generation.

Authors:  Jun Wan; Nadira Vadaq; Joke Konings; Martin Jaeger; Vinod Kumar; Bas de Laat; Leo Joosten; Mihai G Netea; Andre J van der Ven; Philip G de Groot; Quirijn de Mast; Mark Roest
Journal:  J Thromb Haemost       Date:  2021-09-28       Impact factor: 16.036

6.  Visualizing Leukocyte Rolling and Adhesion in Angiotensin II-Infused Mice: Techniques and Pitfalls.

Authors:  Jeremy Lagrange; Sabine Kossmann; Klytaimnistra Kiouptsi; Philip Wenzel
Journal:  J Vis Exp       Date:  2018-01-04       Impact factor: 1.355

7.  Thrombin generation in different commercial sodium citrate blood tubes.

Authors:  Salvagno Gian Luca; Davide Demonte; Matteo Gelati; Giovanni Poli; Emmanuel J Favaloro; Giuseppe Lippi
Journal:  J Med Biochem       Date:  2020-01-10       Impact factor: 3.402

8.  Combined life-threatening thromboses and hemorrhages in a patient with afibrinogenemia and antithrombin deficiency.

Authors:  S Le Quellec; A Desjonqueres; L Rugeri; H Desmurs Clavel; F Farhat; L Mechtouff; Y Dargaud
Journal:  Thromb J       Date:  2018-04-04

9.  Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability.

Authors:  Sara Calzavarini; Justine Brodard; Claudia Quarroz; Livia Maire; Raphael Nützi; Jovana Jankovic; Laura C Rotondo; Evelyne Giabbani; Georg Martin Fiedler; Michael Nagler; Anne Angelillo-Scherrer
Journal:  Res Pract Thromb Haemost       Date:  2019-07-18

10.  The effect of emicizumab and bypassing agents in patients with hemophilia - An in vitro study.

Authors:  Nina Haagenrud Schultz; Heidi Glosli; Stine Bjørnsen; Pål Andre Holme
Journal:  Res Pract Thromb Haemost       Date:  2021-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.